Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
|Articles|November 22, 2022
Episode 31: Bladder Cancer Matters Podcast How COVID Changed How Bladder Cancer Doctors and Patients Interact with Dr. Sima Porten
Advertisement
In Episode 31 of Bladder Cancer Matters, host Rick Bangs talks with Dr. Sima Porten, a urologic cancer surgeon at the University of California San Francisco, about how COVID changed the way that bladder cancer doctors and patients interact.
Rick and Dr. Porten talk about:
- Some of the experiences of patients during the COVID-19 pandemic
- How medical distancing impacted Dr. Porten personally as well as her colleagues
- How she used telemedicine during the pandemic
- The use of in-home tests for bladder cancer that used to be done in a doctor’s office
- Disparities in bladder cancer medical care
- How COVID impacted bladder cancer clinical trial operations
Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network.
Advertisement
Related to this article
Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.
Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.
Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Nearly Half of Cancer Survivors Report Recent Alcohol Use
3
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5